Related by context. All words. (Click for frequent words.) 71 Peg IFN 70 comparator arm 69 lopinavir r arm 69 alfa 2a 68 lopinavir r 67 log# copies mL 67 ritonavir boosted atazanavir 67 oxycodone CR 66 mcg QD 66 plus dexamethasone 66 #mg BID [001] 66 ribavirin RBV 66 humanized interleukin 6 66 R# #mg BID 66 cEVR 66 peginterferon alfa 66 Copegus ribavirin 65 tenofovir emtricitabine 65 receiving INTRON 65 pegylated interferon alfa 2b 65 RGT arm 65 plus gemcitabine 65 CIMZIA TM 65 q8h 65 pegylated interferon alpha 65 abacavir lamivudine 65 peginterferon alfa 2b 64 mg qd 64 pegylated interferon peg IFN 64 ribavirin therapy 64 Peginterferon Alfa 2a 64 REYATAZ r 64 ACTEMRA TM 64 mcg BID 64 mg BID 64 trastuzumab Herceptin R 64 infusional 5-FU/LV 64 Viread Emtriva Sustiva 64 mg QD 64 ABC/3TC 64 #mg BID [003] 64 SVR# 64 BARACLUDE ® 64 q#h 63 mg TID 63 peg IFN 63 placebo dexamethasone 63 Xeloda ® 63 telaprevir dosed 63 alfa 2b 63 mcg dose 63 PREZISTA r 63 plus prednisone 63 μg dose 63 peginterferon alfa 2a 63 carboplatin paclitaxel 63 plus GP IIb 63 Pegasys ® 63 saline placebo 63 PegIFN RBV 63 Pegasys peginterferon alfa 2a 63 PEGASYS ® 63 clodronate 63 virus HCV protease inhibitor 63 FOLFOX4 alone 63 Engerix B 63 mcg albinterferon alfa 2b 63 HBeAg negative patients 63 HBeAg positive patients 63 mg q#h 63 ® emtricitabine 62 5-FU/LV 62 achieved ACR# 62 COPEGUS 62 Folfox 62 ug dose 62 FOLFOX 62 virologic failure 62 treatment naive genotype 62 discontinuations due 62 evaluating tivozanib 62 achieved sustained virologic 62 valopicitabine 62 Aptivus ® 62 VELCADE melphalan 62 mg RDEA# 62 PegIFN 62 pegylated interferon alfa 2a 62 experienced virologic failure 62 Fludara 62 hypophosphatemia 62 plus OBT 62 amprenavir 62 TDF FTC 62 oral levofloxacin 62 treatment naïve genotype 62 Pegylated interferon 62 active comparator 62 plus ribavirin 62 PREZISTA ritonavir 62 PEG Intron 62 REYATAZ r arm 62 alpha 2b 62 plus methotrexate 62 mcg kg 62 #mg dose [002] 61 sustained virologic response 61 azathioprine 61 mcg kg REBETOL 61 peg interferon 61 mg kg dose 61 SPRYCEL ® 61 log# IU mL 61 chlorambucil 61 Peginterferon alfa 2a 61 ALVESCO 61 Alkeran 61 piperacillin tazobactam 61 mg m² 61 infliximab monotherapy 61 8mg/kg 61 PREZISTA r arm 61 #.#mg/dL 61 LPV r 61 FluCAM 61 mg ustekinumab 61 events AEs 61 ritonavir boosted 61 zolmitriptan 61 posaconazole 61 telaprevir pegylated interferon 61 Flu Cy 61 FOLFOX6 chemotherapy regimen 61 CR nPR 61 tazobactam 61 neutropenia dehydration dyspnea 61 COMBIVIR 61 Median PFS 61 nasopharyngitis 61 daunorubicin 61 severe neutropenia 61 #mg/day [002] 61 peginterferon 61 plus prednisone prednisolone 61 Hycamtin ® 61 Pegintron 61 dexamethasone Decadron 61 telaprevir VX 61 interferon ribavirin 61 adalimumab Humira 61 Copegus ® 61 ALT elevation 61 HBeAg seroconversion 60 dasatinib Sprycel ® 60 ug kg 60 mycophenolate mofetil 60 peginterferon alpha 2a 60 low dose cytarabine 60 statin monotherapy 60 mapatumumab 60 zonisamide SR 60 Chronic Hepatitis C 60 mg BID dose 60 Viread Emtriva 60 LEXIVA r 60 atazanavir sulfate 60 Mg Uk 60 adefovir 60 pegylated interferon alfa 60 receiving VICTRELIS 60 peginterferon alfa 2a Pegasys 60 alpha 2a 60 cells uL 60 budesonide pMDI 60 TMC# r 60 PEG interferon 60 mg eq 60 azathioprine monotherapy 60 prednisone prednisolone plus 60 doxorubicin cyclophosphamide 60 pegylated interferon 60 FOLFOX6 60 biologic DMARD 60 atazanavir ritonavir 60 Pegasys plus Copegus 60 plus glycoprotein IIb 60 CCyR 60 mg Lucentis 60 sustained virological response 60 aminotransferase elevations greater 60 fosamprenavir 60 log# reduction 60 REYATAZ R 60 CIMZIA TM certolizumab pegol 60 rapid virologic response 60 cytarabine daunorubicin 60 PEGINTRON TM 60 #mg QD [002] 60 fluvastatin 59 doripenem 59 docetaxel Taxotere R 59 REYATAZ ® 59 mg tid 59 RLAI 59 trimethoprim sulfamethoxazole 59 HCV RESPOND 2 59 PREZISTA rtv 59 salmeterol fluticasone 59 Copegus 59 microgram kg 59 gemcitabine cisplatin 59 plus COPEGUS 59 COPEGUS R 59 dapagliflozin plus 59 rizatriptan 59 Virologic 59 receiving prophylactic anticoagulation 59 genotype 1b 59 Treatment Naive Patients 59 3TC lamivudine Epivir 59 Contrave# 59 cetuximab Erbitux R 59 dacarbazine 59 Peginterferon 59 leukopenia 59 zidovudine lamivudine 59 telbivudine 59 PEG Interferon lambda 59 -#.# log# 59 amoxicillin clavulanate 59 ribavirin 59 interferon alfa 2a 59 oral allopurinol 59 ACR# response 59 cisplatin vinorelbine 59 cabazitaxel 59 Sustiva efavirenz 59 virologically suppressed 59 5 FU leucovorin 59 DOXIL 59 #mg/m# [001] 59 adjunctive placebo 59 Pharmacokinetic parameters 59 FOLFIRI 59 mg/m2 dose 59 estramustine 59 p = NS 59 relapsed MM 59 FOLPI 59 mitoxantrone plus 59 FUSILEV enhances 59 ertapenem 59 FOLFOX4 59 seroprotection 59 ARCOXIA 59 nevirapine Viramune 59 administered concomitantly 58 apremilast 58 3mg/kg 58 CANCIDAS 58 febrile neutropenia 58 sorafenib tablets 58 PASI scores 58 q#d 58 COPEGUS ribavirin 58 anthracycline taxane 58 IU mL 58 lopinavir ritonavir Kaletra 58 lispro 58 Acetate Rectal Suppositories 58 AZT zidovudine Retrovir 58 infliximab 58 Elitek 58 metformin sulfonylurea 58 naïve HCV 58 -#.# log# copies mL 58 HCV genotype 58 tipranavir r 58 ara C 58 undetectable HCV RNA 58 pegIFN 58 alanine aminotransferase 58 docetaxel Taxotere ® 58 emtricitabine tenofovir 58 virologic response 58 #mg BID [002] 58 lenalidomide Revlimid R 58 VIRAMUNE 58 microg 58 PEGylated anti 58 Epivir 58 copies mL 58 decitabine 58 #mg doses [002] 58 Rebetol 58 MCyR 58 PEG IFN 58 Roche Pegasys 58 Taxotere ® 58 Gemzar ® 58 pegylated interferons 58 microbiological eradication 58 Hepsera 58 rilpivirine 58 #mg/kg [002] 58 diuretic chlorthalidone 58 mg dose 58 boosted protease inhibitor 58 patients coinfected 58 efavirenz EFV 58 hematologic toxicity 58 BUPHENYL 58 plasma HCV RNA 58 azilsartan medoxomil 58 APTIVUS r 58 Ribavirin 58 cyclophosphamide methotrexate 58 ULORIC 58 desvenlafaxine succinate 58 cyclophosphamide doxorubicin vincristine 58 viral kinetics 58 PegIntron 58 mcg doses 58 mCi kg 58 mg subcutaneously 58 INTELENCE 58 benazepril 58 neuropathy sensory 58 Zometa hazard 58 imipenem 57 interferon alfa 57 Hazard Ratio 57 taribavirin 57 adriamycin 57 4mg/kg 57 Q2W 57 lopinavir 57 interferon alfa 2b 57 HBeAg positive 57 NRTI 57 adefovir treated 57 Free Survival PFS 57 Tipranavir 57 ALT flares 57 EPIVIR 57 CIMZIA ™ 57 #mg #mg #mg [003] 57 Copegus R 57 treatment naļve 57 gemcitabine carboplatin 57 #mg/day [001] 57 sorafenib Nexavar R 57 TRIZIVIR 57 MAGE A3 ASCI 57 TYGACIL 57 antiretroviral naive 57 balsalazide 57 ketoconazole 57 lamivudine 57 adalimumab 57 mg/m2/day 57 μg kg 57 tenofovir Viread 57 Pegasys R 57 undetectable virus HCV 57 doxazosin 57 seropositive patients 57 nadroparin 57 lamivudine 3TC 57 PEGINTRON 57 transaminases 57 #mg QD [001] 57 docetaxel chemotherapy 57 INVANZ 57 BARACLUDE R 57 TNF antagonists 57 hypokalemia 57 copies ml 57 patients evaluable 57 Pegasys Copegus 57 injected subcutaneously 57 dalteparin 57 HBeAg negative 57 achieved CCyR 57 mitoxantrone 57 celgosivir 57 mg/# hr 57 pegylated liposomal doxorubicin 57 Peginterferon alfa 2b 57 chronic HCV genotype 57 idraparinux 57 efavirenz emtricitabine 57 pyrazinamide 57 valsartan amlodipine 57 HCV genotype 1 57 anemia hemoglobin 57 ng dL 57 adefovir dipivoxil 57 REBETOL 57 administered subcutaneously 57 melphalan prednisone 57 CTAP# Capsules 57 indinavir 57 PROCTOCORT ® Suppository Hydrocortisone 57 cobicistat 57 low dose Iluvien 57 sotalol 57 chemotherapy gemcitabine 57 ribavirin USP 57 dose dexamethasone 57 lumbar spine BMD 57 plasma uric acid 57 Response Evaluation Criteria 57 tenofovir FTC 57 HCV SPRINT 57 pegylated IFN 57 interferon gamma 1b 57 febuxostat 57 response CCyR 57 danazol 57 EUFLEXXA R 56 certolizumab 56 lopinavir ritonavir 56 voriconazole 56 fluticasone salmeterol 56 HBeAg 56 oxaliplatin Eloxatin 56 cisplatin gemcitabine 56 bendamustine 56 Traficet EN 56 receiving ISENTRESS 56 -#.# mg dL [002] 56 #mg q8h 56 coinfected 56 Lupuzor ™ 56 morphometric vertebral fractures 56 tipranavir 56 protease inhibitor PI 56 dose cytarabine 56 XELOX 56 Emtriva Viread 56 darbepoetin alfa 56 tenofovir disoproxil fumarate 56 chronic HCV infection 56 aspartate aminotransferase 56 antiretroviral naïve 56 Fludara ® 56 Paraplatin ® 56 μg doses 56 elevated ALT 56 rifabutin 56 comparator PI r 56 CR CRu 56 oxycodone IR 56 steroid dexamethasone 56 investigational protease inhibitor 56 null responders 56 neutrophil counts 56 recurrent genital herpes 56 HIV RNA 56 baseline HbA1c 56 oral olanzapine 56 bone marrow reticulin deposition 56 pegylated interferon alpha 2a 56 octreotide LAR 56 sorafenib Nexavar ® 56 Nitazoxanide 56 Doxil ® 56 generalized edema 56 anakinra 56 daily Infergen 56 Vfend 56 evaluable patients 56 tolvaptan 56 Kivexa 56 urate lowering therapy 56 IFN alfa 56 tirofiban 56 pomalidomide 56 dasatinib 56 enalapril 56 median survivals 56 trandolapril 56 erlotinib Tarceva ® 56 ACR# responses 56 nevirapine NVP 56 bortezomib refractory 56 ISENTRESS 56 reduce serum phosphate 56 e antigen HBeAg 56 oral vancomycin 56 evaluable subjects 56 ® lenalidomide 56 ceftazidime 56 Adverse events 56 potent CYP#A# inhibitors 56 mcg mL 56 ATACAND 56 Ixempra 56 mg/# hours 56 visilizumab 56 Darunavir 56 Ticagrelor 56 docetaxel Taxotere 56 nitazoxanide 56 leuprorelin 56 #mg dose [003] 56 BENICAR HCT 56 + PH# 56 undetectable viral load 56 PEG INTRON R 56 kBq kg 56 highly emetogenic 56 RNA copies mL 56 recurrent VTE 56 #.#mg/kg [002] 56 paliperidone ER 56 mitoxantrone chemotherapy 56 AmBisome 56 mometasone 56 seroconverted 56 lamivudine monotherapy 56 telaprevir dosing 56 Levofloxacin 56 oral deforolimus 56 valacyclovir 55 mg subcutaneous 55 transaminase elevations 55 IFN α 55 zidovudine 55 #.#/#.# mmHg [001] 55 achieved PASI 55 seroconversion 55 biphasic insulin aspart 55 aspirin heparin 55 TYKERB 55 ORENCIA ® 55 mU liter 55 MIC# [001] 55 fluconazole 55 IIIa inhibitors 55 x ULN 55 endoscopic remission 55 efavirenz 55 complete cytogenetic response 55 IIIa inhibitor 55 myelodysplastic myeloproliferative diseases 55 plus MTX 55 5 Fluorouracil 55 forodesine 55 FASLODEX 55 Amgen Neulasta ® 55 boosted atazanavir 55 patients receiving ERBITUX 55 Jevtana 55 ramipril 55 Zerit 55 Relapsed Refractory 55 enfuvirtide 55 Telbivudine 55 aldosterone antagonist 55 APTIVUS 55 dose cohorts 55 VICTRELIS 55 ibandronate 55 ribavirin Copegus 55 undetectable viral 55 μmol L 55 1mg 2mg 55 caspofungin 55 mcg linaclotide 55 VFEND 55 fluticasone 55 incidence ≥ 55 See CONTRAINDICATIONS 55 OADs 55 Monotherapy 55 virological failure 55 GSK# [001] 55 darunavir ritonavir 55 d4T 55 Index CDAI 55 concentration Cmax 55 Tarceva TM 55 leucopenia 55 mcg kg min 55 nilotinib 55 Tekamlo 55 intravenous bisphosphonates 55 dose cohort 55 evaluable 55 levofloxacin 55 Taxotere R 55 leflunomide 55 glycated hemoglobin levels 55 normal ULN 55 statistical significance p 55 DEB# 55 Solid Tumors criteria 55 ceftaroline 55 Thal Dex 55 TNF antagonist 55 entecavir 55 lamivudine zidovudine 55 vaccine serotypes 55 moderate renal impairment 55 nelfinavir 55 fasting plasma glucose FPG 55 antiandrogen 55 lopinavir ritonavir plus 55 tipranavir ritonavir 55 ONGLYZA 55 ritonavir boosted lopinavir 55 azacitidine 55 metastatic GIST 55 QTcF 55 darunavir r 55 metformin HCl 55 #.#g/day 55 BUPHENYL R sodium phenylbutyrate 55 definite stent thrombosis 55 oral antidiabetic 55 Adalimumab 55 serum urate 55 dexamethasone 55 albinterferon alfa 2b 55 Irinotecan 55 DAS# remission 55 stage IIIb IV 55 REVLIMID ® 55 pegylated alpha interferon 55 mitomycin 55 PRADAXA #mg 55 mg/m2 IV 55 leukemia AML 55 mg Androxal 55 pertuzumab 55 Cream USP 1 55 baseline A1C 55 % CI #.#-#.# [007] 55 Pegylated Interferon 55 timolol 55 maximally tolerated dose 54 atazanavir 54 tolterodine ER 54 vinorelbine 54 lymphocytosis 54 reactogenicity 54 recurrent glioblastoma multiforme 54 deep venous thromboses 54 JANUVIA 54 ug ml 54 mg orally 54 PEG INTRON 54 Bezielle 54 refractory NSCLC 54 complete cytogenetic 54 % Confidence Interval 54 mg FV 54 intramuscularly 54 argatroban 54 goserelin 54 FOLFIRI alone 54 NATRECOR R 54 HCV Genotype 54 biochemical relapse 54 ZYVOX 54 adjunctive ABILIFY 54 NOXAFIL 54 flutamide 54 monotherapy 54 % CI #.#-#.# [003] 54 primary hypercholesterolemia 54 serum phosphorus 54 virologic responses 54 unfractionated heparin 54 rFSH 54 transcriptase inhibitors 54 TYZEKA 54 Crohn Disease Activity 54 COZAAR 54 gemcitabine Gemzar 54 VIRAMUNE XR 54 Zidovudine Tablets 54 darunavir 54 Pharmacokinetics PK 54 Kaplan Meier estimates 54 bevacizumab Avastin ® 54 PEG Intron ® 54 placebo PBO 54 RECIST Response Evaluation Criteria 54 amphotericin B 54 log# 54 NATRECOR ® 54 Femara letrozole 54 tapentadol ER 54 omega interferon 54 annualized relapse 54 CTA# Injection 54 partial remissions 54 LEXIVA 54 umol L 54 palonosetron 54 CAELYX 54 fluoropyrimidine 54 vicriviroc 54 ALT normalization 54 cidofovir 54 mg q8h 54 non splenectomized 54 retapamulin 54 mRCC 54 dose ritonavir 54 pimecrolimus cream 54 combination REBETOL PEG 54 IU ml 54 tigecycline 54 solifenacin 54 oral rivaroxaban 54 glucuronide 54 levosimendan 54 tamsulosin 54 idarubicin 54 mcg Albuferon 54 micafungin 54 aspartate aminotransferase AST 54 isoproterenol 54 jana.mlcochova @ thomson.com 54 efavirenz Sustiva 54 quetiapine 54 genotypic resistance 54 TORISEL 54 nab paclitaxel 54 binary restenosis 54 del 5q MDS 54 Pred Forte 54 azacytidine 54 fluorouracil 54 ARIXTRA 54 Cmax 54 Viramidine 54 palifermin 54 BMS # 54 CHOP chemotherapy 54 postmenopausal osteoporotic women 54 Targretin 54 low dose ritonavir 54 sUA levels 54 fluorouracil leucovorin 54 AZT 3TC 54 placebo p = 54 inhalations twice 54 IXEMPRA 54 Didanosine 54 elevated transaminases 54 ethambutol 54 low dose dexamethasone 54 BEACOPP 54 HCV RNA 54 tocilizumab 54 bexarotene 54 TAXOTERE R 54 mIU ml 54 docetaxel Injection Concentrate 54 oral FTY# 54 atorvastatin Lipitor 54 β blocker 54 gout flares 54 lumbar spine bone 54 antibody titers 54 undetectable HBV DNA 54 Telintra 54 conventional DMARDs 53 TMC# [001] 53 Emtriva 53 sitagliptin 53 virologically 53 degarelix 53 dosing cohorts 53 HBV DNA 53 prucalopride 53 otamixaban 53 Tamibarotene 53 ZIAGEN 53 gadobutrol 53 underwent surgical resection 53 splenectomized patients 53 oxcarbazepine 53 DX DEC# 53 doxorubicin docetaxel 53 R abatacept 53 5mg/kg 53 bortezomib Velcade R 53 iodixanol 53 mg Proellex 53 INVEGA ® 53 vincristine doxorubicin 53 insulin detemir 53 subcutaneous enoxaparin 53 KRAS mutations occur 53 alkylating agent 53 etravirine 53 Median survival 53 prednisone prednisolone 53 corticosteroid dose 53 Dasatinib 53 epoetin beta 53 olmesartan 53 Arch Intern Med 53 relapsed multiple myeloma 53 bicalutamide 53 mg/m2 53 hypomagnesemia 53 urate lowering 53 R entecavir 53 Moxifloxacin 53 miconazole 53 Primary endpoints 53 systemic embolism 53 Median progression 53 FTC TDF 53 micrograms mL 53 CrCl 53 huN# DM1 53 paclitaxel carboplatin 53 achieve sustained virological 53 valsartan 53 etanercept 53 Forodesine HCl 53 inactive placebo 53 pg ml 53 Durezol 53 median PFS 53 Lenalidomide 53 plus medroxyprogesterone acetate 53 intravenous bolus 53 FFNS 53 DLTs 53 glatiramer acetate 53 atazanavir Reyataz 53 terfenadine 53 oral ribavirin 53 thromboembolic events 53 beclomethasone dipropionate 53 RECIST criteria 53 randomized #:# 53 peginterferon alfa 2a #KD 53 DMARD 53 fumarate 53 #mg/dl 53 median CD4 53 imatinib 53 NPH insulin 53 irbesartan 53 μg ml 53 stavudine d4T 53 6 mercaptopurine 53 chlorthalidone 53 titrated glipizide 53 ARIKACE 53 virologic breakthrough 53 dose regimens 53 NMIBC 53 thiazolidinedione 53 achieve sustained virologic 53 sUA 53 tinidazole 53 hour bronchodilation 53 nucleoside reverse transcriptase inhibitor 53 aflibercept 53 iniparib BSI 53 raltegravir 53 Capecitabine 53 nonfatal MI 53 SGPT 53 endometrial ovarian 53 urinary N telopeptide 53 mCi m 2 53 leucovorin 53 clopidogrel Plavix 53 serum HBV DNA 53 TELINTRA 52 Bevacizumab 52 CRESTOR #mg 52 sulphonylurea 52 alanine aminotransferase ALT 52 mycophenolate mofetil MMF 52 #mg ATC 52 Lopinavir ritonavir 52 disease modifying antirheumatic 52 ALT elevations 52 gemcitabine chemotherapy 52 fluticasone furoate 52 bosentan 52 NRTIs 52 lamivudine refractory patients 52 #ug [001] 52 stage IIIB 52 pimozide 52 mg kg Hematide 52 polymerase inhibitor 52 receiving immunosuppressive therapy 52 peginterferon ribavirin 52 Pemetrexed 52 weekly subcutaneous injections 52 hyperphenylalaninemia HPA due 52 systemic absorption 52 sorafenib Nexavar 52 paclitaxel Taxol ® 52 temsirolimus 52 ARIMIDEX 52 DMARDs 52 tenofovir DF 52 oral antidiabetic medication 52 proguanil 52 hepatitis C genotype 52 indinavir Crixivan 52 LANTUS R 52 Velcade bortezomib 52 pegfilgrastim 52 CCR5 tropic HIV 52 uric acid lowering 52 placebo 52 injected intramuscularly 52 microgram mcg 52 Ishak fibrosis score 52 ceftriaxone 52 Apidra ® 52 Combination therapy 52 TMC# [002] 52 medroxyprogesterone acetate 52 formoterol fumarate 52 pCR 52 nonnucleoside reverse transcriptase inhibitors 52 Cutaneous T 52 standard chemotherapy regimen 52 MADRS score 52 STELARA 52 8mg 52 remission CR 52 rifapentine 52 mg dosed twice 52 anthracycline containing 52 DAPT 52 mg p = 52 Epzicom 52 TNF inhibitor 52 mg/# h 52 CCR5 tropic 52 K ras mutations 52 dizziness nausea diarrhea 52 DU #b 52 naive HCV 52 linezolid 52 intravenous REOLYSIN 52 ZOLINZA 52 fluticasone propionate 52 oral clodronate 52 Anti TNF 52 lymphoid blast 52 TPV r 52 d4T stavudine Zerit 52 Neutropenia 52 cells mcL 52 achieved statistical significance 52 abciximab 52 golimumab CNTO 52 Elvitegravir 52 REMICADE ® 52 hip BMD 52 prior chemotherapy regimens 52 J Am Coll 52 nmol liter 52 NNRTIs 52 HIV coinfected 52 R darbepoetin alfa 52 mg simvastatin 52 Lamivudine 52 NNRTI resistance 52 mg d 52 angiotensin receptor blocker ARB 52 Decitabine 52 intra articular injection 52 placebo intravenously 52 cis retinoic acid 52 topotecan 52 NOLVADEX 52 mucosal healing 52 lymphocyte count 52 HBeAg + 52 NOXAFIL Oral Suspension 52 REVLIMID lenalidomide 52 CIMZIA R 52 triamcinolone 52 pulmonary exacerbations 52 blood phenylalanine Phe 52 nucleoside analogue 52 EGFR TKI 52 subcutaneously administered